Gender disparities in time-to-initiation of cardioprotective glucose-lowering drugs in patients with type 2 diabetes and cardiovascular disease: a nationwide cohort study

被引：0
|
作者：
Funck, K. L. [1 ]
Bjerg, L. [1 ]
Isaksen, A. A. [1 ]
Sandbaek, A. [1 ]
Grove, E. L. [2 ]
机构：
[1] Aarhus Univ Hosp, Steno Diabet Ctr Aarhus, Aarhus, Denmark
[2] Aarhus Univ Hosp, Dept Cardiol, Aarhus N, Denmark
来源：
DIABETOLOGIA | 2022年 / 65卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
336
引用
收藏
页码：S176 / S176
页数：1
相关论文
共 50 条
  • [21] Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes
    Kabadi, Udaya M.
    ANNALS OF INTERNAL MEDICINE, 2021, 174 (01) : 140 - 140
  • [22] Trial Compares Glucose-Lowering Drugs for Type 2 Diabetes
    Slomski, Anita
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (16): : 1581 - 1581
  • [23] Initiation of glucose-lowering therapy in Type 2 diabetes mellitus patients in general practice
    Spoelstra, JA
    Stolk, RP
    Klungel, OH
    Erkens, JA
    Rutten, GEHM
    Leufkens, HGM
    Grobbee, DE
    DIABETIC MEDICINE, 2004, 21 (08) : 896 - 900
  • [24] Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study
    Luis M. Pérez-Belmonte
    José David Torres-Peña
    María D. López-Carmona
    M. Mar. Ayala-Gutiérrez
    Francisco Fuentes-Jiménez
    Lucía Jorge Huerta
    Jaime Alonso Muñoz
    Manuel Rubio-Rivas
    Manel Madrazo
    Marcos Guzmán Garcia
    Beatriz Vicente Montes
    Joaquim Fernández Sola
    Javier Ena
    Ruth Gonzalez Ferrer
    Carmen Mella Pérez
    Carlos Jorge Ripper
    Jose Javier Napal Lecumberri
    Iris El Attar Acedo
    Susana Plaza Canteli
    Sara Fuente Cosío
    Francisco Amorós Martínez
    Begoña Cortés Rodríguez
    Pablo Pérez-Martínez
    José Manuel Ramos-Rincón
    Ricardo Gómez-Huelgas
    BMC Medicine, 18
  • [25] Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study
    Perez-Belmonte, Luis M.
    Torres-Pena, Jose David
    Lopez-Carmona, Maria D.
    Ayala-Gutierrez, M. Mar.
    Fuentes-Jimenez, Francisco
    Huerta, Lucia Jorge
    Munoz, Jaime Alonso
    Rubio-Rivas, Manuel
    Madrazo, Manel
    Garcia, Marcos Guzman
    Montes, Beatriz Vicente
    Sola, Joaquim Fernandez
    Ena, Javier
    Ferrer, Ruth Gonzalez
    Perez, Carmen Mella
    Ripper, Carlos Jorge
    Lecumberri, Jose Javier Napal
    Acedo, Iris El Attar
    Canteli, Susana Plaza
    Cosio, Sara Fuente
    Martinez, Francisco Amoros
    Rodriguez, Begona Cortes
    Perez-Martinez, Pablo
    Ramos-Rincon, Jose Manuel
    Gomez-Huelgas, Ricardo
    BMC MEDICINE, 2020, 18 (01)
  • [26] Cardiovascular Disease and Oral Agent Glucose-Lowering Therapies in the Management of Type 2 Diabetes
    Home, Philip
    DIABETES TECHNOLOGY & THERAPEUTICS, 2012, 14 : S33 - S42
  • [27] CARDIOVASCULAR AND MORTALITY OUTCOMES WITH GLP-1 RECEPTOR AGONISTS VS. OTHER GLUCOSE-LOWERING DRUGS IN PATIENTS WITH NAFLD AND TYPE 2 DIABETES: A NATIONWIDE MULTICENTER MATCHED COHORT STUDY
    Krishnan, Arunkumar
    Schneider, Carolin
    Mukherjee, Diptasree
    Woreta, Tinsay A.
    Alqahtani, Saleh A.
    GASTROENTEROLOGY, 2023, 164 (06) : S3 - S3
  • [28] Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes RESPONSE
    Tsapas, Apostolos
    Karagiannis, Thomas
    Avgerinos, Ioannis
    Matthews, David R.
    Bekiari, Eleni
    ANNALS OF INTERNAL MEDICINE, 2021, 174 (01) : 141 - 141
  • [29] Association between Glucose-lowering Treatments and Risk of Diabetic Retinopathy in People with Type 2 Diabetes: A Nationwide Cohort Study
    Jensen, Jakob Hasselstrom
    Vestergaard, Peter
    Jensen, Morten Hasselstrom
    CURRENT DRUG SAFETY, 2024, 19 (02) : 236 - 243
  • [30] Cardiovascular outcome trials of glucose-lowering strategies in type 2 diabetes
    Yudkin, John S.
    Vijan, Sandeep
    Sussman, Jeremy B.
    Lehman, Richard
    Goldacre, Ben M.
    LANCET, 2014, 384 (9948): : 1095 - 1095
12345